Liver transplantation for hepatocellular carcinoma: the MELD impact
- PMID: 14755775
- DOI: 10.1002/lt.20012
Liver transplantation for hepatocellular carcinoma: the MELD impact
Abstract
The new allocation policy of the United Network of Organ Sharing (UNOS) based on the model for end-stage liver disease (MELD) gives candidates with stage T1 or stage T2 hepatocellular carcinoma (HCC) a priority MELD score beyond their degree of hepatic decompensation. The aim of this study was to determine the impact of the new allocation policy on HCC candidates before and after the institution of MELD. The UNOS database was reviewed for all HCC candidates listed between July 1999 and July 2002. The candidates were grouped by two time periods, based on the date of implementation of new allocation policy of February 27, 2002. Pre-MELD candidates were listed for deceased donor liver transplantation (DDLT) before February 27,2002, and post-MELD candidates were listed after February 27, 2002. Candidates were compared by incidence of DDLT, time to DDLT, and dropout rate from the waiting list because of clinical deterioration or death, and survival while waiting and after DDLT. Incidence rates calculated for pre-MELD and post-MELD periods were expressed in person years. During the study, 2,074 HCC candidates were listed for DDLT in the UNOS database. The DDLT incidence rate was 0.439 transplant/person years pre-MELD and 1.454 transplant/person years post-MELD (P < 0.001). The time to DDLT was 2.28 years pre-MELD and 0.69 years post-MELD (P < 0.001). The 5-month dropout rate was 16.5% pre-MELD and 8.5% post-MELD (P < 0.001). The 5-month waiting-list survival was 90.3% pre-MELD and 95.7% post-MELD (P < 0.001). The 5-month survival after DDLT was similar for both time periods. The new allocation policy has led to an increased incidence rate of DDLT in HCC candidates. Furthermore, the 5-month dropout rate has decreased significantly. In addition, 5-month survival while waiting has increased in the post-MELD period. Thus, the new MELD-based allocation policy has benefited HCC candidates.
Similar articles
-
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.Liver Transpl. 2007 Jun;13(6):857-66. doi: 10.1002/lt.21155. Liver Transpl. 2007. PMID: 17539006
-
Liver transplantation in the MELD era: a single-center experience.Dig Dis Sci. 2006 Jun;51(6):1070-8. doi: 10.1007/s10620-006-8011-1. Dig Dis Sci. 2006. PMID: 16865573
-
Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.Liver Transpl. 2004 May;10(5):621-30. doi: 10.1002/lt.20159. Liver Transpl. 2004. PMID: 15108253
-
Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?Liver Transpl. 2007 Nov;13(11 Suppl 2):S36-43. doi: 10.1002/lt.21329. Liver Transpl. 2007. PMID: 17969067 Review.
-
[The value of MELD in the allocation of priority for liver transplantation candidates].Gastroenterol Hepatol. 2010 Apr;33(4):330-6. doi: 10.1016/j.gastrohep.2009.04.007. Epub 2009 Jul 23. Gastroenterol Hepatol. 2010. PMID: 19631411 Review. Spanish.
Cited by
-
Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.Ann Surg. 2004 Sep;240(3):451-9; discussion 459-61. doi: 10.1097/01.sla.0000137129.98894.42. Ann Surg. 2004. PMID: 15319716 Free PMC article.
-
Surgical treatment of hepatocellular carcinoma.Surg Today. 2009;39(10):833-43. doi: 10.1007/s00595-008-4024-z. Epub 2009 Sep 27. Surg Today. 2009. PMID: 19784720 Review.
-
Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?Hepatol Int. 2019 Mar;13(2):190-198. doi: 10.1007/s12072-019-09930-x. Epub 2019 Jan 24. Hepatol Int. 2019. PMID: 30680672
-
Disentangling the effects of race and socioeconomic factors on liver transplantation rates for hepatocellular carcinoma.Clin Transplant. 2016 Jun;30(6):714-21. doi: 10.1111/ctr.12739. Epub 2016 Apr 30. Clin Transplant. 2016. PMID: 27027869 Free PMC article.
-
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.Abdom Radiol (NY). 2016 May;41(5):963-9. doi: 10.1007/s00261-015-0623-5. Abdom Radiol (NY). 2016. PMID: 27193793 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical